• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Microchip Technology Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement

    3/25/25 4:08:47 PM ET
    $MCHP
    Semiconductors
    Technology
    Get the next $MCHP alert in real time by email
    8-K
    MICROCHIP TECHNOLOGY INC NASDAQ false 0000827054 0000827054 2025-03-25 2025-03-25 0000827054 us-gaap:CommonStockMember 2025-03-25 2025-03-25 0000827054 dei:AdrMember 2025-03-25 2025-03-25

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported)

    March 25, 2025

     

     

    LOGO

    MICROCHIP TECHNOLOGY INCORPORATED

    (Exact Name Of Registrant As Specified In Its Charter)

     

     

     

    Delaware   0-21184   86-0629024

    (State Or Other Jurisdiction

    Of Incorporation)

     

    (Commission

    File No.)

      (IRS Employer
    Identification No.)

    2355 West Chandler Boulevard, Chandler, Arizona 85224-6199

    (Address Of Principal Executive Offices, Including Zip Code)

    (480) 792-7200

    (Registrant’s Telephone Number, Including Area Code)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class

     

    Trading
    Symbol

     

    Name of Each Exchange

    on Which Registered

    Common Stock, $0.001 par value per share   MCHP   NASDAQ Stock Market LLC
    Depositary Shares, each representing a 1/20th interest in a share of 7.50% Series A Mandatory Convertible Preferred Stock, $0.001 Par Value   MCHPP   NASDAQ Stock Market LLC
    (Nasdaq Global Select Market)

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

     

     

     


    Item 1.01

    Entry into a Material Definitive Agreement

    On March 25, 2025 (the “Effective Date”), Microchip Technology Incorporated, a Delaware corporation (the “Company”), entered into a Second Amended and Restated Credit Agreement (the “Restated Credit Agreement”) pursuant to which its existing Amended and Restated Credit Agreement, dated as of December 16, 2021 (as amended prior to the Effective Date, the “Existing Credit Agreement”), by and among the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent, was amended and restated in its entirety. The Restated Credit Agreement provides for an unsecured revolving loan facility (the “Revolving Loans”) in an aggregate principal amount of up to $2,250.0 million, with a $250.0 million foreign currency sublimit, a $25.0 million letter of credit sublimit and a $20.0 million swingline loan sublimit. As of the Effective Date, there were no Revolving Loans and no letters of credit outstanding under the Restated Credit Agreement. The proceeds of loans made under the Restated Credit Agreement may be used for working capital and general corporate purposes.

    The Revolving Loans bear interest, at the Company’s option, at the base rate plus a spread of 0.0% to 0.50%, an adjusted daily simple SOFR rate (or SONIA rate in the case of loans denominated in pounds sterling) plus a spread of 0.875% to 1.50%, or an adjusted term SOFR or adjusted EURIBOR rate (based on one, three or six-month interest periods) plus a spread of 0.875% to 1.50%, in each case, with such spread being determined based on the credit ratings for certain of the Company’s senior, unsecured debt. The base rate means the highest of the prime rate, the federal funds rate plus a margin equal to 0.50% and the adjusted term SOFR rate for a 1-month interest period plus a margin equal to 1.00%. Interest is due and payable in arrears quarterly for loans bearing interest at the base rate and at the end of an interest period (or at each three-month interval in the case of loans with interest periods greater than three months) in the case of loans bearing interest at the adjusted term SOFR or adjusted EURIBOR rates. The Company is also obligated to pay other customary closing fees, arrangement fees, administration fees, commitment fees and letter of credit fees for a credit facility of this size and type.

    The Company may borrow, repay and reborrow Revolving Loans until March 25, 2030, at which time the commitments will terminate and all outstanding loans, together with all accrued and unpaid interest, must be repaid. Amounts not borrowed under the Restated Credit Agreement will be subject to a commitment fee, payable in arrears on the last day of each fiscal quarter, ranging from 0.075% to 0.20% per annum determined based on the credit ratings for certain of the Company’s senior, unsecured debt. The Company may prepay the revolving loans and terminate the revolving loan commitments, in whole or in part, at any time without premium or penalty, subject to certain conditions, including minimum amounts and reimbursement of certain costs in the case of prepayments of adjusted term SOFR or adjusted EURIBOR loans.

    The Amended and Restated Credit Agreement also permits the Company to add one or more incremental term loan facilities and/or increase the revolving loan commitments under the Restated Credit Agreement from time to time, so long as the aggregate amount of such increases or additional term loans does not exceed $1.0 billion, subject, in each case, to the receipt of additional commitments from existing and/or new lenders and pro forma compliance with financial covenants as set forth in the Restated Credit Agreement.

    The Company’s obligations under the Restated Credit Agreement are guaranteed by certain of its domestic subsidiaries meeting materiality thresholds set forth in the Restated Credit Agreement. Upon satisfaction of certain conditions specified in the Restated Credit Agreement and at the Company’s election, such guarantees shall be released and shall no longer be required.

    The Restated Credit Agreement contains customary affirmative and negative covenants, including covenants that limit or restrict the Company and its subsidiaries’ ability to, among other things, incur subsidiary indebtedness, grant liens, merge or consolidate, dispose of substantially all assets of the Company and its subsidiaries, taken as a whole, make investments, make acquisitions, enter into certain transactions with affiliates, pay dividends or make distributions, repurchase stock, and enter into restrictive agreements, in each case subject to customary exceptions for a credit facility of this size and type. Upon satisfaction of certain conditions specified in the Restated Credit Agreement and at the Company’s election, certain of such negative covenants in the Restated Credit Agreement shall no longer apply. The Restated Credit Agreement also includes financial maintenance covenants, requiring the Company to maintain compliance with a maximum total leverage ratio and a consolidated minimum interest coverage ratio, each determined in accordance with the terms of the Restated Credit Agreement.


    The Restated Credit Agreement contains customary events of default including, among others, non-payment defaults, inaccuracy of representations and warranties, covenant defaults, cross default to material indebtedness, bankruptcy and insolvency defaults, material judgment defaults, ERISA defaults and a change of control default. The occurrence of an event of default could result in the acceleration of the obligations under the Restated Credit Agreement and termination of the revolving commitments. Under certain circumstances, a default interest rate will apply on all obligations during the existence of an event of default under the Restated Credit Agreement at a per annum rate equal to 2.00% above the applicable interest rate for any overdue principal and 2.00% above the rate applicable for base rate loans for any other overdue amounts.

    Certain of the lenders under the Restated Credit Agreement and their affiliates have engaged in, and may in the future engage in, investment banking, commercial lending and other commercial dealings in the ordinary course of business with the Company or the Company’s affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.

    The foregoing description of the Restated Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the Restated Credit Agreement, which is filed as Exhibit 10.1 hereto and incorporated by reference herein.

     

    Item 2.03

    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The information set forth in Item 1.01 above is incorporated herein by reference.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d)  Exhibits

     

    Exhibit
    Number

      

    Exhibit Description

    10.1    Second Amended and Restated Credit Agreement, dated as of March 25, 2025, by and among Microchip Technology Incorporated, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: March 25, 2025     MICROCHIP TECHNOLOGY INCORPORATED
        By:  

    /s/ J. Eric Bjornholt

         

    J. Eric Bjornholt

    Senior Vice President and Chief Financial Officer

    Get the next $MCHP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MCHP

    DatePrice TargetRatingAnalyst
    6/18/2025$70.00Neutral
    Cantor Fitzgerald
    5/9/2025$60.00 → $65.00Strong Buy
    Raymond James
    5/9/2025$50.00 → $55.00Buy
    Citigroup
    5/9/2025$55.00 → $60.00Buy
    UBS
    5/9/2025$60.00 → $75.00Buy
    B. Riley Securities
    5/9/2025$35.00 → $55.00Hold
    TD Cowen
    5/9/2025$43.00 → $52.00Hold
    Truist
    5/9/2025$60.00 → $70.00Buy
    Stifel
    More analyst ratings

    $MCHP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SENIOR VP AND CFO Bjornholt James Eric sold $112,397 worth of shares (2,015 units at $55.78) (SEC Form 4)

      4 - MICROCHIP TECHNOLOGY INC (0000827054) (Issuer)

      5/27/25 5:01:29 PM ET
      $MCHP
      Semiconductors
      Technology
    • Director Johnson Karlton D sold $29,981 worth of shares (494 units at $60.69), decreasing direct ownership by 12% to 3,468 units (SEC Form 4)

      4 - MICROCHIP TECHNOLOGY INC (0000827054) (Issuer)

      5/22/25 6:16:23 PM ET
      $MCHP
      Semiconductors
      Technology
    • CHIEF OPERATING OFFICER Simoncic Richard J exercised 4,412 shares at a strike of $60.80 and covered exercise/tax liability with 1,208 shares (SEC Form 4)

      4 - MICROCHIP TECHNOLOGY INC (0000827054) (Issuer)

      5/19/25 5:16:01 PM ET
      $MCHP
      Semiconductors
      Technology

    $MCHP
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Microchip Technology Incorporated

      SCHEDULE 13G/A - MICROCHIP TECHNOLOGY INC (0000827054) (Subject)

      6/5/25 11:11:31 AM ET
      $MCHP
      Semiconductors
      Technology
    • SEC Form SD filed by Microchip Technology Incorporated

      SD - MICROCHIP TECHNOLOGY INC (0000827054) (Filer)

      5/30/25 3:49:02 PM ET
      $MCHP
      Semiconductors
      Technology
    • SEC Form S-3ASR filed by Microchip Technology Incorporated

      S-3ASR - MICROCHIP TECHNOLOGY INC (0000827054) (Filer)

      5/9/25 4:31:01 PM ET
      $MCHP
      Semiconductors
      Technology